Verbindungen Eli Lilly and Company

Aktien

858560

US5324571083

LLY

Pharmazeutika

Realtime-Estimate Cboe BZX 18:08:17 15.01.2025 % 5 Tage % 1. Jan.
749,48 USD +0,61 % Intraday Chart für Eli Lilly and Company -5,19 % -3,33 %

50

Börsennotierte Unternehmen

50

Private Unternehmen

843

Insiders

Beziehungs-Chart der börsennotierten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene börsennotierte Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Beziehungs-Chart der privaten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene private Unternehmen: Eli Lilly and Company

The Business Roundtable

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

The Business Council

Miscellaneous Commercial Services

Lilly Research Laboratories

Miscellaneous Commercial Services

Third Rock Ventures LLC

Investment Managers

Duke University

Other Consumer Services

Indianapolis Museum of Art, Inc.

Other Consumer Services

Intersect Illinois

Miscellaneous Commercial Services

American Society of Clinical Oncology, Inc.

Medical/Nursing Services

Millendo Therapeutics US, Inc.

Pharmaceuticals: Major

Harvard Medical School

Other Consumer Services

National Academy of Sciences

Miscellaneous Commercial Services

Apexian Pharmaceuticals, Inc.

Pharmaceuticals: Major

American Chemical Society

Miscellaneous Commercial Services

Twilight Venture Partners LLC

Investment Managers

National Academy of Engineering

Miscellaneous Commercial Services

National Association of Corporate Directors (Virginia)

Miscellaneous Commercial Services

Indiana University Foundation, Inc.

Investment Trusts/Mutual Funds

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Society of Biological Psychiatry

American Diabetes Association Research Foundation, Inc.

American Psychiatric Association

Miscellaneous Commercial Services

University of Indianapolis

Other Consumer Services

Indiana University

Other Consumer Services

ImClone LLC

Biotechnology

Indiana University Health, Inc.

Medical/Nursing Services

Indiana University Health Bloomington, Inc.

Hospital/Nursing Management

Avillion LLP

Pharmaceuticals: Major

Project HOPE-The-People-To-People HealthFoundation, Inc.

Medical/Nursing Services

Radiant Medical, Inc.

Medical Specialties

CS-Keys, Inc.

Medical Specialties

Sorbent Therapeutics, Inc.

Pharmaceuticals: Major

Lilly Endowment, Inc.

Financial Conglomerates

Eiteljorg Museum of American Indians & Western Art

Other Consumer Services

Flowco, Inc.

Medical Specialties

National Association of Manufacturers

Miscellaneous Commercial Services

Pharmaceutical Research & Manufacturers of America

Biotechnology

Arsenal Capital Management LP

Investment Managers

WCG Clinical, Inc.

Biotechnology

DePauw University

Other Consumer Services

Cerecin, Inc.

Pharmaceuticals: Major

The Children's Museum of Indianapolis, Inc.

Other Consumer Services

Marian University

Other Consumer Services

Kovina Therapeutics, Inc.

Miscellaneous Commercial Services

Brock Capital Group LLC

Investment Managers

Aktive Beziehungen

Vergangene Beziehungen

Verbindungsstatistiken

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Aktivitäten der verbundenen Unternehmen

Pharmaceuticals: Major24
Biotechnology16
Miscellaneous Commercial Services16
Other Consumer Services12
Medical Specialties7
Investment Managers5
Medical/Nursing Services3
Packaged Software2
Food: Specialty/Candy1
Home Improvement Chains1

Länder der verbundenen Unternehmen

Vereinigte Staaten91
Vereinigtes Königreich3
Dänemark2
China2
Belgien1
Cayman Islands1
Logo Eli Lilly and Company
Eli Lilly and Company zählt zu den weltweit führenden Pharmakonzernen. Der Umsatz je nach Therapiebereich ist wie folgt verteilt: - Endokrinologie (57,7%): Produkte zur Behandlung von Osteoporose, Diabetes und Wachstumsprobleme; - Onkologie (19,5%); - Immunerkrankungen (11,1%); - Neurologie (8,4%): im Wesentlichen Medikamente zur Depression- und Schizophrenie- Behandlung; - sonstige (3,3%). Die geographische Umsatzverteilung ist folgende: USA (63,9%), Europa (18,1%), Japan (4,9%), China (4,5%) und sonstige (8,6%).
Beschäftigte
43.000
Mehr Unternehmensinformationen